Eli Lilly, an American pharmaceutical company that is studying a cocktail of monoclonal antibodies, has made public in a note the phase 3 results of ...
It stimulates the immune system’s response against the novel coronavirus, but it is still unclear whether it will effectively protect against infection. These are, in ...